Recent advances and therapeutic journey of coumarins: Current status and perspectives

Medicinal Chemistry Research

Volumn 24, Issue 7, 2015, Pages 2771-2798

  Barot, Kuldipsinh P ^a   Jain, Shailesh V ^a   Kremer, Laurent ^b,c   Singh, Shubhra ^b,d,e   Ghate, Manjunath D ^a  

^a NIRMA UNIVERSITY   (India)

^b CNRS   (France)

^c INSERM   (France)

^d IFTM UNIVERSITY   (India)

^e CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Chemistry; Coumarins; Metabolism; Pharmacological activities; Prodrug strategies

Indexed keywords

COUMARIN DERIVATIVE; PRODRUG;

ACUTE DISEASE; ANTIDEPRESSANT ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; BREAST CARCINOMA; CHRONIC DISEASE; DRUG SYNTHESIS; HUMAN; LEUKEMIA; LUNG CANCER; NONHUMAN; REVIEW; STOMACH CANCER; STRUCTURE ACTIVITY RELATION;

EID: 84944157291     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-015-1350-8     Document Type: Review

References (207)

1. Ajani OO, Obafemi CA, Nwinyi OC, Akinpelu DA (2010) Microwave assisted synthesis and antimicrobial activity of 2-quinoxalinone-3-hydrazone derivatives. Bioorg Med Chem 18:214-221
2. Alonso MT, Brunet E, Hernandez C, Rodríguez-Ubis JC (1993) Synthesis and complexation properties of 3-Aroylcoumarin crown ethers. A new class of photoactive macrocycles. Tetrahedron Lett 34:7465-7481
3. Amir E, Freedman OC, Seruga B, Evans DG (2010) Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 102:680-691
4. Anand N, Jaiswal N, Pandey SK, Srivastava AK, Tripathi RP (2011) Application of click chemistry towards an efficient synthesis of 1,2,3-1H-triazolyl glycohybrids as enzyme inhibitors. Carbohydr Res 346:16-25
5. Anand P, Singh B, Singh N (2012) A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease. Bioorg Med Chem 20:1175-1180
6. Aoife L, O'Kennedy R (2004) Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr Pharm Des 10:3797-3811
7. Aoyama Y, Katayama T, Yamamoto M, Tanaka H, Kon K (1992) A new antitumor antibiotic product, demethylchartreusin. Isolation and biological activities. J Antibiot 45:875-878
8. Au N, Rettie AE (2008) Pharmacogenomics of 4-hydroxycoumarin anticoagulants. Drug Metab Rev 40:355-375
9. Baloglu E, Kingston DGI, Patel P, Chatterjee SK, Bane SL (2001) Synthesis and microtubule binding of fluorescent paclitaxel derivatives. Bioorg Med Chem Lett 11:2249-2256
10. 2 . Free Radic Biol Med 33:691-702
11. Barbouti A, Amorgianiotis C, Kolettas E, Kanavaros P, Galaris D (2007) Hydrogen peroxide inhibits caspase-dependent apoptosis by inactivating procaspase-9 in an iron-dependent manner. Free Radic Biol Med 43:1377-1387
12. Barton D, Ollis WD (1979) Comprehensive organic chemistry: the synthesis and reactions of organic compounds, vol 4, 1st edn. Pergamon Press, UK, pp 1205-1207
13. Basile A, Sorbo S, Spadaro V (2009) Antimicrobial and antioxidant activities of coumarins from the roots of Ferulago campestris (apiaceae). Molecules 14:939-952
14. Béchet JJ, Dupaix A, Yon J, Wakselman M, Robert JC, Vilkas M (1973) Inactivation of α-chymotrypsin by a bifunctional reagent, 3,4-dihydro-3,4-dibromo-6-bromomethylcoumarin. Eur J Biochem 35:527-539
15. Bogan D, Deasy B, O'Kennedy R, Smyth M (1995) Determination of free and total 7-hydroxycoumarin in urine and serum by capillary electrophoresis. J Chromatogr B 663:371-378
16. Bogan D, Deasy B, O'Kennedy R, Smyth M (1996) The use of capillary electrophoresis for studying interspecies differences in coumarin metabolism in liver microsomes. Xenobiotica 26:437-448
17. Bonsignore L, Cottiglia F, Elkail H, Jehl F, Lavagna SM, Loy G, Manna F, Monteil G, Pompei D, Secci D (1998) Synthesis and antimicrobial activity of coumarin 7-substituted cephalosporins and sulfones. Farmaco 53:425-430
18. Borges F, Roleira F, Milhazes N, Santana L, Uriarte E (2005a) Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. Curr Med Chem 12:887-916
19. Borges F, Roleira F, Milhazes N, Santana L, Uriarte E (2005b) Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. Curr Med Chem 12:887-916
20. Born SL, Api AM, Ford RA, Lefever FR, Hawkins DR (2003) Comparative metabolism and kinetics of coumarin in mice and rats. Food Chem Toxicol 41:247-258
21. 450 enzymes. Phytochem Rev 5:293-308
22. Braccio MD, Grossi GC, Roma G, Signorello MG, Leoncini G (2004) Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1- piperazinyl) coumarins. Eur J Med Chem 39:397-399
23. Bruhlmann C, Ooms F, Carrupt PA, Testa B, Catto M (2001) Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase. J Med Chem 44:3195-3199
24. Bylov IE, Vasylyev MV, Bilokin YV (1999) Synthesis and anti-inflammatory activity of N-substituted 2-oxo-2H-1-benzopyran-3-carboxamides and their 2-iminoanalogues. Eur J Med Chem 34:997-1001
25. Camarasa MJ, Velázquez S, San-Félix A, Pérez-Pérez MJ, Gago F (2006) Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase: a single mode of inhibition for the three HIV enzymes. Antiviral Res 71:260-267
26. Camenisch GP, Wang W, Wang B, Borchardt RT (1998) A comparison of the bioconversion rates and the Caco-2 cell permeation characteristics of coumarin-based cyclic prodrugs and methylester-based linear prodrugs of RGD peptidomimetics. Pharm Res 15:1174-1182
27. Capra JC, Cunha MP, Machado DG (2010) Antidepressant-like effect of scopoletin, a coumarin isolated from Polygala sabulosa (Polygalaceae) in mice: evidence for the involvement of monoaminergic systems. Eur J Pharmacol 643:232-238
28. Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM (2000) Antiretroviral therapy in adults: updated recommendations of the international AIDS society-USA panel. JAMA 283:381-390
29. Chen YC, Cheung YT, Kong LD (2008) Transcriptional regulation of corticotrophin releasing factor gene by furocoumarins isolated from seeds of Psoralea corylifolia. Life Sci 82:1117-1121
30. Chen Y, Liu HR, Liu HS (2012) Design, synthesis and pharmacological study of S- and O-substituted 7-mercapto- or hydroxycoumarins and chromones as potent cytotoxic agents. Eur J Med Chem 49:74-85
31. Cheng JF, Chen M, Wallace D, Tith S, Arrhenius T, Kashiwagi H, Ono Y, Ishikawa A, Sato H, Kozono T, Sato H, Nadzan AM (2004) Discovery and structure-activity relationship of coumarin derivatives as TNF-α inhibitors. Bioorg Med Chem Lett 14:2411-2415
32. Cherng JM, Chiang W, Chiang LC (2008) Immunomodulatory activities of common vegetables and spices of Umbelliferae and its related coumarins and flavonoids. Food Chem 106:944-950
33. Chiang CC, Cheng MJ, Peng CF, Huang HY, Chen IS (2010) A novel dimeric coumarin analog and antimycobacterial constituents from Fatoua pilosa. Chem Biodivers 7:1728-1736
34. Chimenti F, Secci D, Bolasco A (2009) Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins. J Med Chem 52:1935-1942
35. Chu CC, Tsai YY, Wang CJ, Lin WL, Tseng TH (2001) Induction of apoptosis by esculetin in human leukemia cells. Eur J Pharmacol 416:25-32
36. Chun K, Park SK, Kim HM, Choi Y, Kim MH, Park CH, Joe BY, Chun TG (2008) Chromen-based TNF-α converting enzyme (TACE) inhibitors: design, synthesis, and biological evaluation. Bioorg Med Chem 16:530-535
37. Cohen AJ (1979) Critical review of the toxicology of coumarin with special reference to interspecies differences in metabolism and hepatotoxic response and their significance to man. Food Cosmet Toxicol 17:277-289
38. De Lima FO, Nonato FR, Couto RD, Barbosa Filho JM, Nunes XP, Ribeiro dos Santos R, Soares MB, Villarreal CF (2011) Mechanisms involved in the antinociceptive effects of 7-hydroxycoumarin. J Nat Prod 74:596-602
39. Deng Y, Nicholson RA (2003) Stimulation by surangin B of endogenous amino acid release from synaptosomes. Toxicon 42:351-358
40. Doucet C, Pochet L, Thierry N, Pirotte B, Delarge J, Reboud-Ravaux M (1999) 6-Substituted 2-oxo-2H-1-benzopyran-3-carbo carboxylic acid as a core structure for specific inhibitors of human leukocyte elastase. J Med Chem 42:4161-4171
41. Du L, Mahdi F, Jekabsons MB, Nagle DG, Zhou YD (2010) An isoprenylated dihydroxycoumarin protonophore that potently uncouples mitochondrial electron transport, disrupts hypoxic signaling in tumor cells. J Nat Prod 73:1868-1872
42. Duenas-Gonzalez A, Garcia-Lopez P, Herrera LA, Medina-Franco JL, Gonzalez-Fierro A, Candelaria M (2008) The prince and the pauper. A tale of anticancer targeted agents. Mol Cancer 7:82-91
43. Dwivedi AP, Kumar S, Varshney V, Singh AB, Srivastava AK, Sahu DP (2008) Synthesis and antihyperglycemic activity of novel N-acyl-2-arylethylamines and N-acyl-3-coumarylamines. Bioorg Med Chem Lett 18:2301-2305
44. Egan D, O'Kennedy R (1992) Rapid and sensitive determination of coumarin and 7-hydroxycoumarin and its glucuronide conjugate in urine and plasma by high performance liquid chromatography. J Chromatogr 582:137-143
45. Egan D, O'Kennedy R (1993) spectrofluorimetric method for the quantification of 7-hydroxycoumarin in urine and plasma using both extracted and unextracted samples. Analyst 118:201-203
46. Egan D, O'Kennedy R, Moran E, Cox D, Prosser E, Thornes RD (1990a) The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab Rev 22:503-529
47. Egan D, O'Kennedy R, Moran E, Cox D, Prosser E, Thornes RD (1990b) The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab Rev 22:503-529
48. Evans JG, Gaunt IF, Lake BG (1979) Two-year toxicity study on coumarin in the baboon. Food Cosmet Toxicol 17:187-193
49. Farmer JA, Gotto AM Jr (1994) Antihyperlipidaemic agents. Drug interactions of clinical significance. Drug Saf 11:301-309
50. Fatma T, Cigdem AK, Kevser E, Fatma SK, Mine K, Kemal HCB (2008) Anticonvulsant activity of furanocoumarins and the essential oil obtained from the fruits of Heracleum crenatifolium. Food Chem 107:990-993
51. Ferreira SB, Sodero ACR, Cardoso MFC (2010) Synthesis, biological activity, and molecular modeling studies of 1H-1,2,3-triazole derivatives of carbohydrates as α-glucosidase inhibitors. J Med Chem 53:2364-2374
52. Finn GJ, Kenealy E, Creaven BS, Egan DA (2002) In vitro cytotoxic potential and mechanism of action of selected coumarins, using human renal cell lines. Cancer Lett 183:61-68
53. Fort DM, Rao K, Jolad SD, Luo J, King SR (2000) Antihyperglycemic activity of Teramnus labialis (Fabaceae). Phytomedicine 6:465-467
54. Galkin A, Fallarero A, Vuorela PM (2009) Coumarins permeability in Caco-2 cell model. J Pharm Pharmacol 61:177-184
55. Gazdar AF, Gao BN, Minna JD (2010) Lung cancer cell lines: useless artifacts or invaluable tools for medical science. Lung Cancer 68:309-318
56. Gellert M, Odea MH, Otoh T (1976) Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase. Proc Natl Acad Sci USA 73:4474-4479
57. Ghate M, Manohar D, Kulkarni V, Shobha R, Kattimani S (2003) Synthesis of vanillin ethers from 4-(bromomethyl) coumarins as anti-inflammatory agents. Eur J Med Chem 38:297-301
58. Giacalone G, Abbas MA, Corea F (2010) Prevention strategies for cardioembolic stroke: present and future perspectives. Prevention strategies for cardioembolic stroke: present and future perspectives. Open Neurol J 15:56-63
59. Gillis AJ, Schuller AP, Skordalakes E (2008) Structure of the tribolium castaneum telomerase catalytic subunit TERT. Nature 455:633-637
60. Gnerre C, Catto M, Leonetti F, Weber P, Carrupt PA, Altomare C, Carotti A, Testa B (2000) Inhibition of monoamine oxidases by functionalized coumarin derivatives: biological activities, QSARs, and 3D-QSAR. J Med Chem 43:4147-4156
61. Goddard JP, Reymond JL (2004) Recent advances in enzyme assays. Trends Biotechnol 22:363-369
62. Gomez-Outes A, Suarez-Gea ML, Calvo-Rojas G (2012) Discovery of anticoagulant drugs: a historical perspective. Curr Drug Discov Technol 9:83-104
63. Grimm EL, Brideau C, Chauret N, Chan CC, Delorme D, Ducharme Y (2006) Substituted coumarins as potent 5-lipoxygenase inhibitors. Bioorg Med Chem Lett 16:2528-2531
64. Guillo LA, Beylot B, Vigny P, Spassky A (1996) Formation of cyclobutane thymine dimers from UVA photosensitization of pyridopsoralen monoadducted DNA. Photochem Photobiol 64:349-356
65. He QL, Chen Y, Qin J, Mo SL, Wei M, Zhang JJ, Zou XN (2012) Osthole, a herbal compound, alleviates nucleus pulposus-evoked nociceptive responses through the suppression of overexpression of acid-sensing ion channel 3 (ASIC3) in rat dorsal root ganglion. Med Sci Monit 18:229-236
66. Henry GW, Yen LC (2008) Aspirin and other antiplatelet drugs in the prevention of venous thromboembolism. Novel anticancer agents, kayeassamins C-1 from the flower of Kayea assamica of Myanmar. Blood Rev 22:107-116
67. Heyduk E, Heyduk T (1997) Thiol-reactive, luminescent Europium chelates: luminescence probes for resonance energy transfer distance measurements in biomolecules. Anal Biochem 248:216-220
68. Hilgert M, Noldner M, Chatterjee SS, Klein J (1999) KA-672 inhibits rat brain acetylcholinesterase in vitro but not in vivo. Neurosci Lett 263:193-198
69. Hirsch AM, Longeon A, Guyot M (2002) Fraxin and esculin: two coumarins specific to Actinidia chinensis and A. deliciosa (kiwifruit). Biochem Syst Ecol 30:55-60
70. Hopkins AL, Ren J, Milton J, Hazen RJ, Chan JH, Stuart DI, Stammers DK (2004) Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. J Med Chem 47:5912-5916
71. Hossain MA, Mihara H, Ueno A (2003) Fluorescence resonance energy transfer in a novel cyclodextrin-peptide conjugate for detecting steroid molecules. Bioorg Med Chem Lett 13:4305-4315
72. Hoult JR, Paya M (1996a) Pharmacological and biochemical action of simple coumarins: natural product with therapeutic potential. Gen Pharmacol 27:713-722
73. Hoult JRS, Paya M (1996b) Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen Pharmacol 27:713-722
74. Hu X, Feng Y, Liu X, Zhao XF, Yu JH, Yang YS, Sydow-Backman M (2007) Effect of a novel non-thiazolidinedione peroxisome proliferator-activated receptor alpha/gamma agonist on glucose uptake. Diabetologia 50:1048-1057
75. Hu XJ, Jin HZ, Xu WZ, Chen M, Liu XH, Zhang W, Su J, Zhang C, Zhang WD (2008) Anti-inflammatory and analgesic activities of Edgeworthia chrysantha and its effective chemical constituents. Biol Pharm Bull 31:1761-1765
76. Huitink GM, Poe DP, Diehl H (1974) On the properties of Calcein Blue. Talanta 21:1221-1226
77. Iranshahi M, Askari M, Sahebkar A, Hadjipavlou-Litina D (2009) Evaluation of antioxidant, anti-inflammatory and lipoxygenase inhibitory activities of the prenylated coumarin umbelliprenin. DARU J Pharm Sci 17:99-103
78. Isabelle K, Marc H, Stephane C, Lionel P, de Pascal T, Foidart JM (2008) 6-Substituted 2-oxo-2H-1-benzopyran-3-carboxylic acid derivatives in a new approach of the treatment of cancer cell invasion and metastasis. Eur J Med Chem 43:2735-2750
79. Iwasaki H, Okabe T, Takara K, Toda T, Shimatani M, Oku H (2010) Tumor-selective cytotoxicity of benzo[c]phenanthridine derivatives from Toddalia asiatica Lam. Cancer Chemother Pharmacol 65:719-726
80. Jiménez-Orozco FA, Rosales AAR, Vega-López A (2011) Differential effects of esculetin and daphnetin on in vitro cell proliferation and in vivo estrogenicity. Eur J Pharmacol 668:35-41
81. Juan MRN, Francisco M, Jose AH, Jose V, Eduardo P (2008) Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation. J Am Coll Cardiol 8:818-826
82. Jurd DL, King JR, Mihara K (1970) The effect of alkylation on the antimicrobial activities of 7-hydroxy- and 4-hydroxycoumarins. Experentia 26:1281-1287
83. Kalkhambkar RG, Kulkarni GM, Kamanavalli CM, Premkumar N, Asdag SMB, Sun CM (2008) Synthesis and biological activities of some new fluorinated coumarins and 1- azacoumarins. Eur J Med Chem 43:2178-2188
84. Kamali F, Pirmohamed M (2006) The future prospects of pharmacogenetics in oral anticoagulation therapy. Br J Clin Pharmacol 61:746-751
85. Kashman Y, Gustafson KR, Fuller WR, Cardellina JM, McMohan JB, Currous MJ, Buckheiy RW, Hughes SH, Cragg GM, Boyd MP (1992) The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. J Med Chem 35:2735-2738
86. Katerinopoulos HE (2004) The coumarin moiety as chromophore of fluorescent ion indicators in biological systems. Curr Pharm Des 10:3835-3841
87. Khan IA, Kulkarni MV, Sun CM (2005) One pot synthesis of oxygenated tri-heterocycles as anti-microbial agents. Eur J Med Chem 40:1168-1175
88. Kim NY, Pae HO, Ko YS (1999) In vitro inducible nitric oxide synthesis inhibitory active constituents from Fraxinus rhynchophylla. Planta Med 65:656-658
89. Kim SH, Kang KA, Zhang R (2008) Protective effect of esculetin against oxidative stress induced cell damage via scavenging reactive oxygen species. Acta Pharmacol Sin 29:1319-1326
90. Kim YA, Kong CS, Yea SS (2010) Constituents of Corydalis heterocarpa and their anti-proliferative effects on human cancer cells. Food Chem Toxicol 48:722-728
91. Kim NH, Kim SN, Oh JS, Lee S, Kim YK (2012) Anti-mitotic potential of 7-diethylamino-3(20′-benzoxazolyl)-coumarin in 5-fluorouracilresistant human gastric cancer cell line SNU620/5-FU. Biochem Biophys Res Commun 418:616-621
92. Kini D, Ghate M (2011) Synthesis and oral hypoglycemic activity of 3-[5′-methyl-2′-aryl-3′-(thiazol-2″-yl amino) thiazolidin-4′-one]-coumarin derivatives. Eur J Chem 8:386-390
93. Kirkiacharian S, Thuy DT, Sicsic S, Bakhchinian R, Kurkjian R, Tonnaire T (2002) Structure-activity relationships of some 3-substituted-4-hydroxycoumarins as HIV-1 protease inhibitors. Farmaco 57:703-706
94. Kocbek P, Hribar G, Gobec S (2011) Biochemical and biological evaluation of novel potent coumarin inhibitor of 17α-HSD type 1. Chem Biol Interact 191:60-65
95. Kohli E, Gaspari M, Raj HG, Parmar VS, Sharma SK, Greef JV, Kumari R (2004) Acetoxy drug: protein transacetylase of buffalo liver-characterization and mass spectrometry of the acetylated protein product. Biochem Biophys Acta 19:55-67
96. Kontogiorgis CA, Hadjipavlou-Litina D (2004) Synthesis and biological evaluation of novel coumarin derivatives with a 7-azomethine linkage. J Bioorg Med Chem Lett 14:611-614
97. Kontogiorgis C, Detsi A, Hadjipavlou-Litina D (2012) Coumarin-based drugs: a patent review. Expert Opin Ther Pat 22:437-454
98. Kostova I, Bhatia S, Grigorov P (2011a) Coumarins as antioxidants. Curr Med Chem 18:3929-3951
99. Kostova I, Bhatia S, Grigorov P, Balkansky S, Parmar VS, Prasad AK, Saso L (2011b) Coumarins as antioxidants. Curr Med Chem 18:3929-3951
100. Kulkarni MV, Kulkarni GM, Chao-Hsiung L, Chung-Ming S (2006) Recent advances in coumarins and 1-azacoumarins as versatile biodynamic agents. Curr Med Chem 13:2795-2818
101. Kumar A, Singh BK, Tyagi R, Jain SK, Sharma SK, Prasad AK, Raj HG, Rastogi RC, Watterson AC (2005) Mechanism of biochemical action of substituted 4-methylcoumarins. Bioorg Med Chem 13:4300-4305
102. Kumar A, Singh BK, Sharma NK, Gyanda K, Jain SK, Tyagi YK, Baghel AS (2007) Specificities of acetoxy derivatives of coumarins, biscoumarins, chromones, flavones, isoflavones and xanthones for acetoxy drug: protein transacetylase. Eur J Med Chem 42:447-455
103. Kurup A, Mekapati SB, Garg R, Hansch C (2003) HIV-1 protease inhibitors: a comparative QSAR analysis. Curr Med Chem 10:1679-1688
104. Kusuma BR, Peterson LB, Zhao HP, Vielhauer G, Holzbeierlein J, Blagg BSJ (2011) Targeting the heat shock protein 90 dimer with dimeric inhibitors. J Med Chem 54:6234-6253
105. Lake B (1999) Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment. Food Chem Toxicol 37:423-453
106. Laurin P, Ferroud D, Klich M, Hamelin CD, Mavais P, Lassaigne P, Bonnefoy A, Musicki B (1999) Synthesis and biological evaluation of novel, selective, nonsteroidal glucocorticoid receptor antagonists. Bioorg Med Chem Lett 9:2079-2083
107. Lee SH, Park C, Jin CY, Kim GY, Moon SK, Hyun JW, Lee WH, Choi BT, Kwon TK, Yoo YH, Choi YH (2008) In-volvement of extracellular signal-related kinase signaling in esculetin induced G1 arrest of human leukemia U937 cells. Biomed Pharmacother 62:723-729
108. Liao Y, Wang B (1999) Substituted coumarins as esterase-sensitive prodrug moieties with improved release rates. Biorg Med Chem Lett 9:1795-1805
109. Liu XH, Liu HF, Chen J (2010) Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents. Bioorg Med Chem Lett 20:5705-5708
110. Lowe NJ, Chizhevsky V, Gabriel H (1997) Photo(chemo)therapy: general principles. Clin Dermatol 15:745-751
111. Madari H, Panda D, Wilson L, Jacobs RS (2003) Dicoumarol: a unique microtubule stabilizing natural product that is synergistic with taxol. Cancer Res 63:1214-1220
112. Manjunath G, Kusanur RA, Kulkarni MV (2005) Synthesis and in vivo analgesic and anti-inflammatory activity of some biheterocyclic coumarin derivatives. Eur J Med Chem 40:882-887
113. Mao WW, Wang TT, Zeng HP, Wang ZY, Chen JP, Shen JG (2009) Synthesis and evaluation of novel substituted 5-hydroxycoumarin and pyranocoumarin derivatives exhibiting significant antiproliferative activity against breast cancer cell lines. Bioorg Med Chem Lett 19:4570-4573
114. Marquez N, Sandro R, Bedoya LM, Alcaoni J, Lopez-Perez JL, Feliciano AS, Fiebich BL, Munoz E (2005) Mesuol, a natural occurring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the NF-kappaB pathway. Antiviral Res 66:137-140
115. Marshall ME, Mohler JL, Edmonds K (1994) An updated review of the clinical development of coumarin (1,2-benzopyrone) and 7-hydroxycoumarin. J Cancer Res Clin Oncol 120:S39-S42
116. Matern U (1991) Coumarins and other phenylpropanoid compounds in the defense response of plant cells. Planta Med 57:15-20
117. Matsuda H, Tomohiro N, Ido Y, Kubo M (2002) Anti-allergic effects of Cnidii monnieri fructus (dried fruits of Cnidium monnieri) and its major component, Osthol. Biol Pharm Bull 25:809-811
118. Mei-Hsiang L, Yu-shiang C, Yan-Jyu T, Duen-suey C (2011) Antioxidant properties of 5, 7-dihydroxycoumarin derivatives in vitro cell-free and cell-containing system. J Expert Clin Med 3:126-131
119. Meotti FC, Ardenghi JV, Pretto JB, Souza MM, AvILA MJ, Junior AC, Pizzolatti MG, Santos ARS (2006) Antinociceptive properties of coumarins, steroid and dihydrostyryl-2-pyrones from Polygala sabulosa (Polygalaceae) in mice. J Pharm Pharmacol 58:107-112
120. Merabet N, Dumond J, Collinet B, Van Baelinghem L, Boggetto N, Ongeri S, Ressad F, Reboud-Ravux M (2004) New constrained "molecular tongs" designed to dissociate HIV-1 protease dimer. J Med Chem 47:6392-6395
121. Meunier B (2008) Hybrid molecules with a dual mode of action: dream or reality. Acc Chem Res 41:69-77
122. Mohareb RM, Fleita DH, Sakka OK (2011) Novel synthesis of hydrazidehydrazone derivatives and their utilization in the synthesis of coumarin, pyridine, thiazole and thiophene derivatives with antitumor activity. Molecules 16:17-27
123. Mohler JL, Gomella LG, Crawford ED, Glode LM, Zippe CD, Fair WR (1992) Phase II evaluation of coumarin(1,2-benzopyrone) in metastatic prostatic carcinoma. Prostate 20:123-131
124. Murren JR, DiStasio SA, Lorico A, McKeon A, Zuhowski EG, Egorin MJ, Sartoreli AC, Rappa G (2000) Phase I and pharmacokinetic study of novobiocin in combination with VP-16 in patients with refractory malignancies. Cancer J 6:256-265
125. Nakamura T, Kodama N, Arai Y, Kumamoto T, Higuchi Y, Haichantipyuth C, Ishikawa T, Ueno K, Yano S (2009) Inhibitory effect of oxycoumairns isolated from the Thai medicinal plant Clausena guillauminii on the inflammation mediators, iNOS, TNFα, and COX-2 expression in mouse macrophage. J Nat Med 63:21-27
126. Nicolaides DN, Fylaktakidou KC, Litinas KE, Hadlipavlou-Litina D (1998) Synthesis and biological evaluation of several coumarin-4-carboxamidoxime and 3-(coumarin-4-yl)-1,2,4-oxadiazole derivatives. Eur J Med Chem 33:715-720
127. Noipha K, Thongthoom T, Songsiang U, Boonyarat C, Yenjai C (2010) Carbazoles and coumarins from Clausena harmandiana stimulate glucose uptake in L6 myotubes. Diabetes Res Clin Pract 90:67-71
128. Ojala T, Vuorela P, Vuorela H, Törnquist K (2001) The coumarin osthol attenuates the binding of thyrotropin-releasing hormone in rat pituitary GH4C1 cells. Planta Med 67:236-241
129. Pahari P, Rohr J (2009) Total synthesis of psoralidin, an anticancer natural product. J Org Chem 74:2750-2754
130. Pelkonen O, Raunio H, Rautio A, Pasanen M, Lang MA (1997) The metabolism of coumarin. Coumarins: biology, applications and mode of action, vol 16. Wiley, Chichester, pp 67-92
131. 450 (CYP) enzymes. Xenobiotica 28:1203-1253
132. 2A6: a human coumarin-7-hydroxylase. Toxicology 144:139-147
133. Pochet L, Doucet C, Schynts M, Thierry N, Boggetto N, Pirotte B, Jiang KY (1996) Esters and amides of 6-(chloromethyl)-2-oxo-2H-1- benzopyran-3-carboxylic acid as inhibitors of alphachymotrypsin: significance of the "aromatic" nature of the novel ester-type coumarin for strong inhibitory activity. J Med Chem 39:2579-2585
134. Pochet L, Doucet C, Dive G, Wouters J, Masereel B, Reboud-Ravaux M, Pirotte B (2000) Coumarinic derivatives as mechanism-based inhibitors of alpha-chymotrypsin and human leukocyte elastase. Bioorg Med Chem 8:1489-1501
135. Podbielkowska M, Piwocka M, Waszkowska E, Waleza M, Zobela M (1995) Effect of coumarin and its derivatives on mitosis and ultrastructure of meristematic cells. Int J Pharmacog 33:7-11
136. Popov D, Raev LD, Voinova E, Ivanov IC (1990) Antitumor activity of some coumarin derivatives. Pharmazie 45(9):696-699
137. Portonovo P, Ding X, Leonard MS, Joullié MM, (2000) First total synthesis of a fluorescent didemnin. Tetrahedron 56: 3687-3690
138. Prince FI, Abdul RB, Amir A (2009) Antiamoebic coumarins from the root bark of Adina cordifolia and their new thiosemicarbazone derivatives. Eur J Med Chem 44:2252-2259
139. Raj HG, Parmar VS, Jain SC, Goel S, Malhotra S, Singh A, Olsen CE, Wengel J (1998) Mechanism of biochemical action of substituted 4-methylbenzopyran-2-ones. Part I: dioxygenated 4-methyl coumarins as superb antioxidant and radical scavenging agents. Bioorg Med Chem 6:833-841
140. Raj HG, Parmar VS, Jain SC, Goel S, Tyagi YK, Sharma SK, Olsen CE (2000a) Mechanism of biochemical action of substituted 4-methylbenzopyran-2-ones. Bioorg Med Chem 8:233-237
141. Raj HG, Parmar VS, Jain SC, Kohhli E, Ahmad N, Goel S, Tyagi YK (2000b) Mechanism of biochemical action of substituted 4 methylbenzopyran-2-ones. Part 7: assay and characterization of 7, 8-diacetoxy-4-methylcoumarin: protein transacetylase from rat liver microsomes based on the irreversible inhibition of cytosolic glutathione Stransferase. Bioorg Med Chem 8: 1707-1712
142. Raj HG, Kohli E, Goswami R, Goel S, Rastogi RC, Jain SC, Wengel J, Olsen CE (2001) Mechanism of biochemical action of substituted benzopyran-2-ones. Part 8: acetoxycoumarin: protein transacetylase specificity for aromatic nuclear acetoxy groups in proximity to the oxygen heteroatom. Bioorg Med Chem 9: 1085-1098
143. Rajitha B, Kumar V, Naveen Someshwar P, Madhav J, Venu Reddy P (2006) Dipyridine copper chloride catalyzed coumarin synthesis via pechmann condensation under conventional heating and microwave irradiation. Arkivoc XII:23-27
144. Ratanasavanh D, Lamiable D, Biour M, Guedes Y, Gersberg M, Leutenegger E, Riche C (1996a) Metabolism and toxicity of coumarin on cultured human, rat, mouse and rabbit hepatocytes. Fundam Clin Pharmacol 10:504-510
145. Ratanasavanh D, Lamiable D, Biour M, Guedes Y, Gersberg M, Leutenegger E, Riche C (1996b) Metabolism and toxicity of coumarin on cultured human, rat, mouse and rabbit hepatocytes. Fundam Clin Pharmacol 10:504-516
146. Rautio A, Kraul H, Kojo A, Salmela E, Pelkonen O (1992) Inter-individual variability in coumarin 7-hydroxylation in healthy individuals. Pharmacogenetics 2:227-233
147. Resch M, Steigel A, Chen ZL, Bauer R (1998) 5-Lipoxygenase and cyclooxygenase-1 inhibitory active compounds from Atractylodes lancea. J Nat Prod 61:347-350
148. Rietjens MCM, Boersma IMG, Zaleska M, Punt A (2008) Differences in simulated liver concentrations of toxic coumarin metabolites in rats and different human populations evaluated through physiologically based biokinetic (PBBK) modeling. Toxicol In vitro 22:1890-1901
149. Riveiro ME, De Kimpe N, Moglioni A, Vázquez R, Monczor F, Shayo C, Davio C (2010a) Coumarins: old compounds with novel promising therapeutic perspectives. Curr Med Chem 17:1325-1330
150. Riveiro ME, De Kimpe N, Moglioni A, Vázquez R, Monczor F, Shayo C, Davio C (2010b) Coumarins: old compounds with novel promising therapeutic perspectives. Curr Med Chem 17: 1325-1328
151. Riveiro ME, De Kimpe N, Moglioni A, Vázquez R, Monczor F, Shayo C (2010c) Coumarins: old compounds with novel promising therapeutic perspectives. Curr Med Chem 17: 1325-1338
152. Riveiro ME, Kimpe ND, Moglioni A (2010d) Coumarins: old compounds with novel promising therapeutic perspectives. Curr Med Chem 17:1325-1338
153. Rodrigues RF, Tashima K, Pereira RMS, Mohamed RS, Cabral FA (2008) Coumarin solubility and extraction from emburana (Torresea cearensis) seeds with supercritical carbon dioxide. J Surpercrit Fluids 43:375-382
154. Roma G, Braccio M, Carrieri A, Grossi GC, Leoninci G, Signorello MG, Carotti A (2003) Coumarin, chromone, and 4(3H)-pyrimidinone novel bicyclic and tricyclic derivatives as antiplatelet agents: synthesis, biological evaluation, and comparative molecular field analysis. Bioorg Med Chem 11:123-127
155. Roy BC, Peterson R, Mallik S, Campiglia AD (2000) Synthesis and fluorescence properties of new fluorescent, polymerizable, metal-chelating lipids. J Org Chem 65:3644-3651
156. Sardari S, Mori Y, Horita K, Micetich RG, Nishibe S, Daneshtalab M (1999) Synthesis and antifungal activity of coumarins and angular furanocoumarins. Bioorg Med Chem 7:1933-1939
157. Sashidhara KV, Kumar A (2011) Discovery and synthesis of novel 3-phenylcoumarin derivatives as antidepressant agents. Bioorg Med Chem Lett 21:1937-1941
158. Sashidhara KV, Rosaiah JN, Bhatia G, Saxena JK (2008) Novel ketoenamine Schiffs bases from 7-hydroxy-4-methyl-2-oxo-2Hbenzo [h] chromene-8,10-dicarbaldehyde as potential antidyslipidemic and antioxidant agents. Eur J Med Chem 43:2592-2596
159. Scott KA, Barnes J, Whitehead RC, Stratford IJ, Nolan KA (2011) Inhibitors of NQO1: identification of compounds more potent than dicoumarol without associated off-target effects. Biochem Pharmacol 81:355-363
160. Shin E, Choi KM, Yoo HS, Lee CK, Hwang BY, Lee MK (2010) Inhibitory effects of coumarins from the stem barks of Fraxinus rhynchophylla on adipocyte differentiation in 3T3-L1 cells. Biol Pharm Bull 33:1610-1614
161. Slamova K, Marhol P, Bezouska K (2010) Synthesis and biological activity of glycosyl-1H-1,2,3-triazoles. Bioorg Med Chem Lett 20:4263-4265
162. Soine TO (1964) Naturally occurring coumarins and related physiological activities. J Pharm Sci 53:231-264
163. Spino C, Dodier M, Sootheeswaran S (1988) Anti-HIV coumarins from Calophyllum seed oil. Bioorg Med Chem Lett 8:3475-3481
164. Stefanachi A, Favia AD, Nicolotti O (2011) Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-hydroxylase/C17-20 lyase. J Med Chem 54:1613-1625
165. 450 isoform-specific in vitro methods to predict drug metabolism and interactions, vol 11. Oulu University Press, Finland, pp 1-28
166. Takechi H, Oda Y, Nishizono N, Oda K, Machida M (2000) Screening search for organic fluorophores: syntheses and fluorescence properties of 3-azolyl-7-diethylaminocoumarin derivatives. Chem Pharm Bull 48:1702-1716
167. Tang CH, Yang RS, Chien MY, Chen CC, Fu WM (2008) Enhancement of bone morphogenetic protein 2 expressions and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts. Eur J Pharmacol 579:40-49
168. Tang YD, Zhang JQ, Zhang SL, Geng RX, Zhou CH (2012) Synthesis and characterization of thiophene-derived amido bis-nitrogen mustard and its antimicrobial and anticancer activities. Chin J Chem 30:1831-1840
169. Thongthoom T, Songsiang U, Phaosiri C, Yenjai C (2010) Biological activity of the chemical constituents from Clausena harmandiana. Arch Pharm Res 33:675-680
170. Thornes RD, Edlow DW, Wood S Jr (1968) Inhibition of locomotion of cancer cells in vivo by anticoagulant therapy. Effects of sodium warfarin on V2 cancer cells, granulocytes and macrophages in rabbits. Johns Hopkins Med J 123:305-316
171. Thornes RD, Daly L, Lynch G, Breslin B, Browne H, Browne HY, Corrigan T, Daly P, Edwards G, Gaffney E (1994) Treatment with coumarin to prevent or delay recurrence of malignant melanoma. J Cancer Res Clin Oncol 12:32-34
172. Tosun F, Kizilay CA, Erol K, Kilic FS, Kurkcuoglu M, Baser KHC (2008) Anticonvulsant activity of furanocoumarins and the essential oil obtained from the fruits of Heracleum crenatifolium. Food Chem 107:990-993
173. Tyagi YK, Kumar A, Raj HG, Parag V, Gupta G, Kumar R, Kumar P, Gupta RK (2005) Synthesis of novel amino and acetyl amino-4-methylcoumarins and evaluation of their antioxidant activity. Eur J Med Chem 40:413-421
174. Vajragupta O, Boonchoong P, Wongkrajang Y (2000) Comparative quantitative structure-activity study of radical scavengers. Bioorg Med Chem 8:2617-2621
175. Vassallo JD, Hicks SM, Daston GP, Lehman-McKeeman LD (2004) Metabolic detoxification determines species differences in coumarin-induced hepatotoxicity. Toxicol Sci 80:249-257
176. Vázquez R, Riveiro ME, Vermeulen M (2012) Toddaculin, a natural coumarin from Toddacia asiatica, induces differentiation and apoptosis in U-937 leukemic cells. Phytomedicine 19:737-746
177. Vazquez-Rodriguez S, Matos MJ, Santana L, Uriarte E, Borges F, Kachler S, Klotz KN (2013) Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists. J Pharm Pharmacol 65:697-703
178. Velasco-Velazquez MA, Agramonte-Hevia J, Barrera D, Jimenez-Orozco A, Garcia-Mondragon MJ (2003) 4-Hydroxycoumarin disorganizes the actin cytoskeleton in B16-F10 melanoma cells but not in B82 fibroblasts, decreasing their adhesion to extracellular matrix proteins and motility. Cancer Lett 198:179-186
179. Venugopala KN, Rashmi V, Odhav B (2013) Review on natural coumarin lead compounds for their pharmacological activity. BioMed Res Int 1:1-14
180. Vergel NE, López JL, Orallo F (2010) Antidepressant-like profile and MAO-A inhibitory activity of 4-propyl-2H-benzo[h]-chromen-2-one. Life Sci 86:819-824
181. Verkman AS (2004) Drug discovery in academia. Am J Physiol Cell Physiol 286:465-474
182. Wang B, Zhang W (1998) Coumarin-based prodrugs. Part 3: structural effects on the release kinetics of esterase-sensitive prodrugs of amines. Bioorg Med Chem 6:417-426
183. Wang B, Zhang H, Wang W (1996a) Chemical feasibility studies of a potential coumarin-based prodrug system. Bioorg Med Chem Lett 6:945-958
184. Wang B, Zhang H, Wang W (1996b) Chemical feasibility studies of a potential coumarin-based prodrug system. Bioorg Med Chem Lett 6:945-950
185. Wang BH, Ternai B, Polya G (1997) Specific inhibition of cyclic AMP-dependent protein kinase by warangalone and robustic acid. Phytochemistry 44:787-796
186. Wang B, Wang W, Camenisch GP, Elmo J (1999a) Synthesis and evaluation of novel coumarin-based esterase-sensitive cyclic prodrugs of peptidomimetic RGD analogs with improved membrane permeability. Chem Pharm Bull 47:90-96
187. Wang W, Jiang J, Ballard CE, Wang B (1999b) Prodrug approaches to the improved delivery of peptide drugs. Orally active peptidomimetic RGD analogs that are glycoprotein IIb/IIIa antagonists. Curr Pharm Des 5:265-276
188. Wang W, Borchardt RT, Wang B (2000a) Orally active peptidomimetic RGD analogs that are glycoprotein IIb/IIIa antagonists. Curr Med Chem 7:437-441
189. Wang W, Camenisch G, Sane DC, Zhang H (2000b) A coumarin-based prodrug strategy to improve the oral absorption of RGD peptidomimetics. J Control Release 65:245-251
190. Watt PM, Hickson ID (1994) Structure and function of type II DNA topoisomerases. Biochem J 303:681-693
191. Weber US, Steffen B, Siegers CP (1998) Antitumor-activities of coumarin, 7-hydroxy-coumarin and its glucuronide in several human tumor cell lines. Res Commun Mol Pathol Pharmacol 99:193-206
192. Whang WK, Park HS, Ham I (2005) Natural compounds, fraxin and chemicals structurally related to fraxin protect cells from oxidative stress. Exp Mol Med 37:436-446
193. Win NN, Awale S, Esumi H, Tezuka Y, Kadota S (2008) Novel anticancer agents, kayeassamins C-1 from the flower of Kayea assamica of Myanmar. Bioorg Med Chem 16:8653-8660
194. Wu L, Wang X, Xu W, Farzaneh F, Xu R (2009) The structure and pharmacological functions of coumarins and their derivatives. Curr Med Chem 16:4236-4260
195. Xia Y, Fan CD, Zhao BX, Zhao J, Shin DS, Miao JY (2008) Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents A549 lung cancer cells. Eur J Med Chem 43:2347-2353
196. Xin-Mei P, Guri LVD, Cheng-He Z (2013) Current developments of coumarin compounds in medicinal chemistry. Curr Pharm Des 19:3884-3930
197. Yang J, Liu GY, Dai F (2011) Synthesis and biological evaluation of hydroxylated 3-phenyl coumarins as antioxidants and antiproliferative agents. Bioorg Med Chem Lett 21:6420-6425
198. Yeni PG, Hermoner SM (2002) Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the international AIDS society-USA Panel. JAMA 288:222-225
199. Yi LT, Li YC, Pan Y (2008) Antidepressant-like effects of psoralidin isolated from the seeds of Psoralea corylifolia in the forced swimming test in mice. Biol Psychiatr 32:510-519
200. You LS, Feng S, An R, Wang XH (2009) Osthole: a promising lead compound for drug discovery from a Traditional Chinese Medicine (TCM), Osthole: a promising led compound for drug discovery from a Traditional Chinese Medicine (TCM). Nat Prod Commun 4:297-302
201. You LS, An R, Wang XH, Li YM (2010) Discovery of novel osthole derivatives as potential anti-breast cancer treatment. Bioorg Med Chem Lett 20:7426-7428
202. Yu D, Suzuki M, Xie L, Morris-Natschke SL, Lee KH (2003) Recent progress in the development of coumarin derivatives as potent anti-HIV agents. Med Res Rev 23:322-345
203. Zaha AA, Hazem A (2002) Antimicrobial activity of two novel coumarin derivatives: 3-cyanonaphtho[1,2-(e)] pyran-2-one and 3-cyanocoumarin. New Microbiol 25:213-216
204. Zhang SL, Damu GLV, Zhang L, Geng RX, Zhou CH (2012) Synthesis and biological evaluation of novel benzimidazole derivatives and their binding behavior with bovine serum albumin. Eur J Med Chem 55:164-175
205. Zheng LW, Wu LL, Zhao BX, Dong WL, Miao YJ (2009) Synthesis of novel substituted pyrazone-5-carbohydrazide hydrazone derivatives and discovery of a potent apoptosis inducer in A549 lung cancer cells. Bioorg Med Chem 17:1957-1962
206. Zych LA, Yang W, Liao Y, Griffin KR, Wang B (2004a) The effect of substitution patterns on the release rates of opioid peptides DADLE and [Leu(5)]-enkephalin from coumarin prodrug moieties. Bioorg Chem 32:109-118
207. Zych LA, Yang W, Liao Y, Griffin KR, Wang B (2004b) The effect of substitution patterns on the release rates of opioid peptides DADLE and [Leu5]-enkephalin from coumarin prodrug moieties. Bioorg Chem 32:109-123